DermTech, Inc. Profile Avatar - Palmy Investing

DermTech, Inc.

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expr…

Medical - Diagnostics & Research
US, La Jolla [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of DMTK's Analysis
CIK: 1651944 CUSIP: 24984K105 ISIN: US24984K1051 LEI: - UEI: -
Secondary Listings
DMTK has no secondary listings inside our databases.